Trials
Search / Trial NCT06431542

Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis

Launched by ZHONGSHAN HOSPITAL XIAMEN UNIVERSITY · May 22, 2024

Apply for Trial

Trial Information

Current as of March 12, 2025

Completed

Keywords

Triamcinolone Acetonide Econazole Cream Otomycosis

ClinConnect Summary

The study analyzes the clinical characteristics, including symptoms and physical examinations, as well as the types of fungal infections. It compares the efficacy of patient self-application versus physician application of triamcinolone acetonide econazole cream in treating otomycosis two weeks after starting treatment. Furthermore, the study also compares the recurrence rates six months after treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 1.The chief complaint was ear discomfort, including tinnitus, a feeling of blockage or fullness, pruritis, otalgia, otorrhea and decreased hearing; 2. Physical examination findings:presence of fungal hyphae or accumulations that appear creamy or cheese-like or resembling abnormal earwax (crusts, films) , skin redness, erosion, swelling, or granulation tissue within the ear canal; 3. Positive results in fungal culture.
  • Exclusion Criteria:
  • • The exclusion criteria included otitis media, tympanic membrane perforation, and conditions post-radiotherapy.

Trial Officials

Chunsheng Chunsheng

Principal Investigator

Xiamen University Zhongshan Hospital

About Zhongshan Hospital Xiamen University

Zhongshan Hospital, affiliated with Xiamen University, is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and exemplary patient care. As a prominent sponsor of clinical trials, the hospital leverages its robust research capabilities and interdisciplinary collaboration to explore novel therapeutic interventions and enhance treatment protocols across various medical fields. Committed to upholding the highest ethical standards, Zhongshan Hospital fosters an environment conducive to scientific inquiry, aiming to improve patient outcomes and contribute to the global medical community.

Locations

Xiamen, Fujian, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0